News
Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...
In early-stage HCC patients (BCLC 0 and A), CP mRNA was elevated in 67.9% of cases, outperforming AFP, which detected only 46 ...
A new study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.
Hepatocellular carcinoma (HCC), the most common form of liver cancer, continues to pose a significant global health challenge ...
As Ho, Yu and colleagues report in the current issue of Cancer Discovery, PLT012 undermines the metabolic checkpoint mediated by CD36 to restore anti-tumor immunity in mouse models of hepatocellular ...
13d
News-Medical.Net on MSNSerum hsa_circ_101555 as a promising biomarker for hepatocellular carcinomaHepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.
One liver cancer, hepatocellular carcinoma (HCC), is associated ... using a high-fat diet-induced non-alcoholic fatty liver mouse model showed that green tea or epigallocatechin gallate (EGCG ...
9d
News Medical on MSNA candidate drug dismantles a metabolic barrier to anti-tumor immunityA Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results